===============================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________
FORM 8-K/A
Amendment No. 1
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
May 1, 2007 (February 22, 2007)
GENE LOGIC INC.
(Exact name of registrant as specified in its charter)
DELAWARE 0-23317 06-1411336
- -------------------------------------------------------------------------------
(State of Incorporation) (Commission File Number) (IRS Employer
Identification Number)
- -------------------------------------------------------------------------------
50 West Watkins Mill Road
Gaithersburg, Maryland 20878
(Address of principal executive offices)
(301) 987-1700
(Registrant's telephone number, including area code)
NA
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[_] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
===============================================================================
SECTION 5. CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02. Departure of Directors or Principal Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
The Company previously reported on a Current Report on Form 8K filed on February
28, 2007, the election of Lloyd I. Miller, III to its Board of Directors. At
that time, he had not been appointed to serve on any Board committees. On April
25, 2007, the Board elected Mr. Miller to serve on its Audit Committee and its
Compensation Committee.
On April 26, 2007, the Board also confirmed that Mr. Miller was elected to serve
as a Director in Class III. The term of that Class expires at the Annual
Stockholders meeting of the Company in 2009.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Gene Logic Inc.
By: /s/ Philip L. Rohrer, Jr.
--------------------------------
Philip L. Rohrer, Jr.
Chief Financial Officer
Dated: May 1, 2007